Stryker is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Kevin A. Lobo, with a market cap of $145.51B.
Upcoming earnings announcement for Stryker
Past 12 earnings reports for Stryker
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q4 2025 | $4.47Est: $4.39 | +1.8% | $7.2BEst: $7.1B | +0.6% | — |
| Oct 30, 2025 | Q3 2025 | $3.19Est: $3.14 | +1.6% | $6.1BEst: $6.0B | +0.2% | |
| Jul 31, 2025 | Q2 2025 | $3.13Est: $3.07 | +2.0% | $6.0BEst: $5.9B | +1.4% | |
| May 1, 2025 | Q1 2025 | $2.84Est: $2.70 | +5.2% | $5.9BEst: $5.7B | +2.9% | |
| Jan 28, 2025 | Q4 2024 | $4.01Est: $3.87 | +3.6% | $6.4BEst: $6.4B | +1.2% | |
| Oct 29, 2024 | Q3 2024 | $2.87Est: $2.77 | +3.6% | $5.5BEst: $5.4B | +2.3% | |
| Jul 30, 2024 | Q2 2024 | $2.81Est: $2.79 | +0.7% | $5.4BEst: $5.4B | +0.2% | |
| Apr 30, 2024 | Q1 2024 | $2.50Est: $2.35 | +6.4% | $5.2BEst: $5.1B | +2.8% | |
| Jan 30, 2024 | Q4 2023 | $3.46Est: $3.27 | +5.8% | $5.8BEst: $5.6B | +3.8% | |
| Nov 2, 2023 | Q3 2023 | $2.46Est: $2.43 | +1.2% | $4.9BEst: $4.9B | +1.0% | — |
| Aug 3, 2023 | Q2 2023 | $2.54Est: $2.38 | +6.7% | $5.0BEst: $4.8B | +3.4% | |
| May 1, 2023 | Q1 2023 | $2.14Est: $2.00 | +7.0% | $4.8BEst: $4.6B | +4.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.